Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 5,053
Out of 5,056 analysts
16
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Beckley | Initiates: Buy | $18 | $3.96 | +354.55% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $24.01 | -29.20% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $5.33 | +537.90% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $145.56 | -34.73% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.43 | -17.70% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $330 | $4.60 | +7,073.91% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $1.19 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $4.95 | +546.46% | 4 | Dec 16, 2020 |
Atai Beckley
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $3.96
Upside: +354.55%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $24.01
Upside: -29.20%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $5.33
Upside: +537.90%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $145.56
Upside: -34.73%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.43
Upside: -17.70%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $330
Current: $4.60
Upside: +7,073.91%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.19
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $4.95
Upside: +546.46%